FDA Clears Cingulate to File for Marketing Approval of
Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application Advancing Discussions with Commercialization Partners...
Source: globenewswire.com
Cingulate Chairman News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cingulate Chairman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cingulate Chairman Today - Breaking & Trending Today
FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD
Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application CTx-1301 Could Benefit >60% of ADHD Patients Currently ...
Source: businessinsider.com
Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board ...
KANSAS CITY, Kan., April 30, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and
Source: eagletribune.com
Cingulate to Host CNS Key Opinion Leader Panel in New York
Expert Analysis of Cingulate, its Phase 3 ADHD Adult Data, Anxiety, and PTR™ Drug Delivery Platform Innovations...
Source: globenewswire.com
Cingulate, Indegene to Participate in Benzinga All Live Access Event
KANSAS CITY, Kan., May 12, 2023 -- Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ drug delivery platform technology to build and advance a... | June 14, 2023
Source: marketscreener.com